KETAMINE TO TREAT DEPRESSION

Aitken, Measurement of feelings using visual analogue scales, Proc. Royal Soc. Med., 62:989-993, 1962. Anand et al., Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists, Arch. Gen. Psychiatry, 57:270-276, 2000. Azevedo et al., Transderrnal ketamine as an adjuvant for postopera tive analgesia after abdominal gynecological Surgery using Lidocaine epidural blockade, Anesth. Anal. , 91: 1479-1482, 2000. Beck et al., Assessment of depression: the depression inventory, Modern Problems Pharmacopsychiatry, 7:151-169, 1974. Berman et al., Antidepressant effects of ketamine in depressed patients, Biol. Psychiatry, 47:351-354, 2000. Bolshakov et al. Determinants of trapping block of N-methyl-daspartate receptor channels, J. Neurochem. , 87:56-65, 2003. Bonanno et al., Ketamine in War/tropical Surgery (a final tribute to the racemic mixture), Injury, 33:323-327, 2002. Bovill et al., Alterations in response to Somatic pain associated with anaesthesia, Br. J. Anaesth. ,43:496-499, 1971. Boyer et al., Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain: a quantitative in situ hybridization study, J. Mol. Neurosci. 10:219-233, 1998. Byrd et al., Behavioral effects of phencyclidine and ketamine alone and in combination with other drugs, Eur, J. Pharmacol. , 144:331 341, 1987. Calabrese et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression, Lamictal 602 Study Group, J. Clin. Psychiatry, 60:79-88, 1999. Carr et al., Safety and efficacy of intranasal ketamine for the treat ment of breakthrough pain in patients with chronic pain: a random ized, double-blind, placebo-controlled, crossover study, Pain, 108:17-27, 2004. Debattista et al., Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, pla cebo-controlled study, Am. J. Psychiatry, 157: 1334-1337, 2000. Devry et al., Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine, Behav. Pharmacol. , 14:229-235, 2003. Domino et al., Pharmacologic effects of ci-581, a new dissociative anesthetic in man, Clin. Pharmacol. Ther. , 40:279-291, 1965. Drevets et al., Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria, Biol. Psychiatry, 49:81–96, 2001. DSa et al., Antidepressants and neuroplasticity, Bipolar Disord. , 4:183-194, 2002. Duman, Synaptic plasticity and mood disorders, Mol. Psychiatry, 7:S29-S34, 2002. Elliott et al., N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development, Neuropsychopharmacology, 13:347-356, 1995. EntSuah et al., Response and remission rates in different Subpopula tions with major depressive disorder administered venlafaxine, selec tive serotonin reuptake inhibitors, or placebo, J. Clin. Psychiatry, 62:869-877, 2001. Fava, Diagnosis and definition of treatment-resistant depression, Biol. Psychiatry, 53:649-659, 2003. Frank et al., Conceptualization and rationale for consensus defini tions of terms in major depressive disorder: remission, recovery, relapse, and recurrence, Arch. Gen. Psychiatry, 48:851-855, 1991. Gutzke et al., Cardiac transplantation: a prospective comparison of ketamine and Sufentanil for anesthetic induction, J. Cardiothorac. Anesth. , 3:389-95, 1989. Hamilton. A rating scale for depression, J. Neurol. NeuroSurg. Psy chiatry, 23:56-62, 1960. Hedlund et al., The Hamilton rating scale for depression, J. Opera tional Psychiatry, 10:149-165, 1979.